Ke-Yi Ye

Bioinspired plant-derived extracellular vesicles enabling dual-targeting therapy for primary ovarian insufficiency.

Extracellular vesicles (EVs) have emerged as promising therapeutic agents for restoring ovarian function and fertility in chemotherapy-induced premature ovarian insufficiency (POI). However, their limited ovarian targeting capacity and inefficient mitochondrial delivery have substantially constrained their therapeutic...